ESHRE Task Force on Ethics and Law 21: Genetic screening of gamete donors: Ethical issues

Human Reproduction

Volumn 29, Issue 7, 2014, Pages 1353-1359

  Dondorp, W ^a   De Wert, G ^a   Pennings, G ^b   Shenfield, F ^c   Devroey, P ^d   Tarlatzis, B ^e   Barri, P ^f   Diedrich, K ^g   Eichenlaub Ritter, U ^h   Tuttelmann F ⁱ   Provoost, V ^b  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^d CENTRE FOR REPRODUCTIVE MEDICINE   (Belgium)

^e ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g UNIVERSITY OF LÜBECK   (Germany)

^h BIELEFELD UNIVERSITY   (Germany)

ⁱ UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

donor conception; ethics; genetic screening; reproductive risk; reproductive safety

Indexed keywords

ARTICLE; DONOR SELECTION; GAMETE; GENE TECHNOLOGY; GENETIC SCREENING; GENOMICS; HUMAN; LAW; MEDICAL ETHICS; PROGENY; RISK REDUCTION; ADVISORY COMMITTEE; ARTIFICIAL INSEMINATION; DONOR; ETHICS; EUROPE; FEMALE; HETEROZYGOTE; INFORMED CONSENT; LEGISLATION AND JURISPRUDENCE; MALE; OOCYTE DONATION; PATIENT SAFETY; PRACTICE GUIDELINE; RISK; UNITED STATES;

ADVISORY COMMITTEES; ETHICS, MEDICAL; EUROPE; FEMALE; GENETIC TESTING; GUIDELINES AS TOPIC; HETEROZYGOTE; HUMANS; INFORMED CONSENT; INSEMINATION, ARTIFICIAL, HETEROLOGOUS; MALE; OOCYTE DONATION; PATIENT SAFETY; RISK; TISSUE DONORS; UNITED STATES;

EID: 84902667377     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu111     Document Type: Article

References (37)

1. ACOG Committee Opinion No. 486: update on carrier screening for cystic fibrosis. Obstet Gynecol 2011;117:1028-1031.
2. Aizpurua J, Szlarb N, Moragues I, Ramos B, Rogel S. Breakthrough/ innovative approach: first genetic matching assay in an oocyte donation programusing preconceptional screening arrays. Abstracts of the 29th Annual Meeting of the European Society of Human Reproduction and Embryology. Hum Reprod 2013;28(Suppl. 1):i25,-061.
3. Ashford M. GenePeeks preconception testing to start with arrays but move to exome and whole-genome sequencing. Genomeweb.com, 7 November 2012. http://www.genomeweb.com/clinical-genomics/genepeeks-preconceptiontesting- start-arrays-move-exome-and-whole-genome-sequenc (6 March 2014, date last accessed).
4. ASRM Practice Committee of American Society for Reproductive Medicine; Practice Committee of Society for Assisted Reproductive Technology. Recommendations for gamete and embryo donation: a committee opinion. Fertil Steril 2013;99:4762.
5. Association of Biomedical Andrologists; Association of Clinical Embryologists; British Andrology Society; British Fertility Society; Royal College of Obstetricians and Gynaecologists. UK guidelines for the medical and laboratory screening of sperm, egg and embryo donors (2008). Hum Fertil (Camb) 2008;11:201-210.
6. Barratt C, Englert Y, Gottlieb C, Jouannet P. Gamete donation guidelines. The Corsendonk consensus document for the European Union. Hum Reprod 1998;13:500-501.
7. Bell CJ, Dinwiddie DL, Miller NA, Hateley SL, Ganusova EE, Mudge J, Langley RJ, Zhang L, Lee CC, Schilkey FD et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci Transl Med 2011;3:65-4.
8. Bream KD, Lott JP. Heritable disease and sperm donation. JAMA 2010; 303:617-618.
9. CECOS website: www.cecos.org (9 March 2014, date last accessed).
10. Chandley AC. Genetic contribution to male infertility. Hum Reprod 1998; 13(Suppl. 3):76-83.
11. Commission Directive 2006/17/EC of 8 February 2006 implementing Directive 2004/23/EC of the European Parliament and of the Council as regards certain technical requirements for the donation, procurement and testing of human tissues and cells, Annex III, 3.6. http://eur-lex.europa.eu/ LexUriServ/LexUriServ.douri=CELEX:32006L0017:EN:NOT (6 March 2014, date last accessed).
12. Crawford DC, Acuña JM, Sherman SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 2001;3:359-371.
13. Daar JF, Brzyski RG. Genetic screening of sperm and oocyte donors: ethical and policy implications. JAMA 2009;302:1702-1704.
14. ESHRE Task Force on Ethics and LawIII. Gamete and embryo donation.Hum Reprod 2002;17:1407-1408.
15. ESHRE Task Force on Ethics and Law, including, Dondorp W, de Wert G, Pennings G, Shenfield F, Devroey P, Tarlatzis B, Barri P. Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod 2010; 25:578583.
16. Fairfax cryobank. http://www.fairfaxcryobank.com/whychoose.shtml (6 March 2014, date last accessed).
17. Kingsmore S. Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases. PLoS Curr 2012;4:e4f9877ab8ffa9. doi:10.1371/4f9877ab8ffa9.
18. Le Lannou D, Thepot F, Jouannet P. Multicentre approaches to donor insemination in the French CECOS Federation: nationwide evaluation, donor matching, screening for genetic diseases and consanguinity. Centre dEtudes et de Conservation des Oeufs et du Sperme humain. Hum Reprod 1998;13(Suppl. 2):35-49.
19. Maron BJ, Lesser JR, Schiller NB, Harris KM, Brown C, RehmHL. Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA 2009;302:1681-1684.
20. McLachlan RI, OBryan MK. Clinical Review#: state of the art for genetic testing of infertile men. J Clin Endocrinol Metab 2010;95:1013-1024.
21. Musci TJ, Moyer K. Prenatal carrier testing for fragile X: counseling issues and challenges. In: Gregg AR, Simpson JL (eds). Genetic screening and counseling. Obstet Gynecol Clin N Am 2010;37:61-70.
22. Okser S, Pahikkala T, Aittokallio T. Genetic variants and their interactions in disease risk prediction - machine learning and network perspectives. BioData Min 2013;6:5.
23. Pennings G, deWert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. Hum Reprod 2007;22:2585-2588.
24. Pennings G, deWert G, Shenfield F, Cohen J, Tarlatzis B, Devroey P. ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. Hum Reprod 2008;23:772-774.
25. Prior TW. Professional Practice and Guidelines Committee. Carrier screening for spinal muscular atrophy. Genet Med 2008;10:840-842.
26. Reh A, Amarosa A, Licciardi F, Krey L, Berkeley AS, Kump L. Evaluating the necessity for universal screening of prospective oocyte donors using enhanced genetic and psychological testing. Hum Reprod 2010; 25:2298-2304.
27. Ravel C, Berthaut I, Bresson JL, Siffroi JP; GeneticsCommission of the French Federation of CECOS. Prevalence of chromosomal abnormalities in phenotypically normal and fertile adult males: large-scale survey of over 10,000 sperm donor karyotypes. Hum Reprod 2006;21: 1484-1489.
28. RichtliniendesArbeitskreises fürDonogeneInsemination zurQualitätssicherung der Behandlung mit Spendersamen in Deutschland 2006. http://www .donogene-insemination.de/downloads/Richtl-Druckfassung.pdf (6 March 2014, date last accessed).
29. Ropers HH. On the future of genetic risk assessment. J Community Genet 2012;3:229-236.
30. Sawyer N, Blyth E, Kramer W, Frith L. A survey of 1700 women who formed their families using donor spermatozoa. RBM Online 2013;27: 436-447.
31. Siffroi JP, Charron P, Bujan L. Heritable disease and sperm donation. JAMA 2010;303:617.
32. Sims CA, Callum P, Ray M, Iger J, Falk RE. Genetic testing of sperm donors: survey of current practices. Fertil Steril 2010;94:126-129.
33. Sterckx S,Cockbain J,Howard HC, Borry P. I prefer a child with . . .: designer babies, another controversial patent in the arena of direct-to-consumer genomics. Genet Med 2013;15:923-924.
34. Thompson PD, Levine BD. Protecting athletes from sudden cardiac death. JAMA 2006;296:1648-1650.
35. Van Assche E, Bonduelle M, Tournaye H, Joris H, Verheyen G, Devroey P, Van Steirteghem A, Liebaers I. Cytogenetics of infertile men. Hum Reprod 1996;11(Suppl. 4):1-24.
36. van El CG, Cornel MC, Borry P, Hastings RJ, Fellmann F, Hodgson SV, Howard HC, Cambon-Thomsen A, Knoppers BM, Meijers-Heijboer H et al.; ESHG Public and Professional Policy Committee. Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet 2013;21(Suppl. 1):S1-S5.
37. Winand R, Hens K, Dondorp W, de Wert G, Moreau Y, Vermeesch JR, Liebaers I, Aerts J. In vitro screening of embryos by whole-genome sequencing: now, in the future or never? Hum Reprod 2014; 29:842-851.